000 01713 a2200493 4500
005 20250518073908.0
264 0 _c20200102
008 202001s 0 0 eng d
022 _a1178-2048
024 7 _a10.2147/VHRM.S226009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlem, Manal M
245 0 0 _aEffect of Long-Term Allopurinol Therapy on Left Ventricular Mass Index in Patients with Ischemic Heart Disease; A Cross-Sectional Study.
_h[electronic resource]
260 _bVascular health and risk management
_c2019
300 _a539-550 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAllopurinol
_xadverse effects
650 0 4 _aAntioxidants
_xadverse effects
650 0 4 _aBiomarkers
_xblood
650 0 4 _aBlood Glucose
_xdrug effects
650 0 4 _aCase-Control Studies
650 0 4 _aCreatinine
_xblood
650 0 4 _aCross-Sectional Studies
650 0 4 _aFemale
650 0 4 _aGlycated Hemoglobin
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHypertrophy, Left Ventricular
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyocardial Ischemia
_xblood
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
650 0 4 _aVentricular Function, Left
_xdrug effects
650 0 4 _aVentricular Remodeling
_xdrug effects
700 1 _aAldosari, Sarah R
700 1 _aAlkahmous, Alhassna A
700 1 _aObad, Adam S
700 1 _aFagir, Nagy M
700 1 _aAl-Ghamdi, Bandar S
773 0 _tVascular health and risk management
_gvol. 15
_gp. 539-550
856 4 0 _uhttps://doi.org/10.2147/VHRM.S226009
_zAvailable from publisher's website
999 _c30411001
_d30411001